Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathryn P. Componeschi"'
Autor:
Antonio C. Wolff, Kathy D. Miller, Kathryn P. Componeschi, Kirsten Timms, Rachel C. Jankowitz, Nadine Tung, Zhenying Tan-Wasielewski, Charles M. Perou, Andrea L. Richardson, Jennifer M. Specht, Vered Stearns, Ian E. Krop, Tiffany A. Traina, Mothaffar F. Rimawi, EP Winer, Lorenzo Trippa, Vandana G. Abramson, Erica L. Mayer, Paul K. Marcom, Lisa A. Carey, Carla I. Falkson
Publikováno v:
Ann Oncol
Background Cisplatin and paclitaxel are active in triple-negative breast cancer (TNBC). Despite different mechanisms of action, effective predictive biomarkers to preferentially inform drug selection have not been identified. The homologous recombina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd4d430b47b75126d84acfb82d53273f
https://europepmc.org/articles/PMC8437015/
https://europepmc.org/articles/PMC8437015/
Autor:
Shannon Puhalla, Michelle E. Melisko, Kimberly L. Blackwell, Polly A. Niravath, Karen L. Smith, Antonio C. Wolff, Kathryn P. Componeschi, Kelly Silvestri, Nadine Tung, Rachel C. Jankowitz, Timothy J. Moynihan, Roisin M. Connolly, Paula R. Pohlmann, Juan M. Marte, Heather A. Parsons, Anne Cropp, Robyn Burns, Nuhad K. Ibrahim, Christine M Cotter, Julie R. Nangia, Rachel A. Freedman, Beverly Moy, Rebecca Gelman, Nan Lin, Mothaffar F. Rimawi, Ian E. Krop, Carey K. Anders, Eric P. Winer, Catherine Van Poznak, Ciara C. O’Sullivan
Publikováno v:
Journal of Clinical Oncology
PURPOSE Evidence-based treatments for metastatic, human epidermal growth factor receptor 2 (HER2)–positive breast cancer to the CNS are limited. We previously reported modest activity of neratinib monotherapy for HER2-positive breast cancer brain m
Autor:
Rachel A. Freedman, Ian E. Krop, Kelly Silvestri, Juan M. Marte, Roisin M. Connolly, Michelle E. Melisko, Robyn Burns, Ian F. Dunn, Beverly Moy, Carey K. Anders, Shannon Puhalla, Nuhad K. Ibrahim, Sandro Santagata, Nathalie Y. R. Agar, Julie R. Nangia, Timothy J. Moynihan, Elizabeth C. Randall, Catherine Van Poznak, Begoña Gimenez-Cassina Lopez, Rebecca Gelman, Kimberly L. Blackwell, Nan Lin, Mothaffar F. Rimawi, Nadine Tung, Christine M Cotter, Antonio C. Wolff, Eric P. Winer, Kathryn P. Componeschi
Publikováno v:
Clinical Breast Cancer. 20:145-151.e2
Purpose This pilot study was performed to test our ability to administer neratinib monotherapy before clinically recommended craniotomy in patients with HER2-positive metastatic breast cancer to the central nervous system, to examine neratinib’s ce
Autor:
Katherine L. Nathanson, Judy Garber, Molin Wang, Leigh Boghossian, Nadine Tung, Erin Hofstatter, Susan M. Domchek, Penelope Miron, Kathryn P. Componeschi, Alexander Miron
Publikováno v:
Familial Cancer. 10:225-231
PALB2 (Partner And Localizer of BRCA2) binds to and co-localizes with BRCA2 in DNA repair. Germline mutations in PALB2 have been identified in approximately 1–2% of familial breast cancer and 3–4% of familial pancreatic cancer cases. The goal of